. Author manuscript; available in PMC: 2014 Jul 1.

Published in final edited form as: Hypertension. 2013 Apr 29;62(1):10.1161/HYPERTENSIONAHA.113.01174. doi: 10.1161/HYPERTENSIONAHA.113.01174

Table 2.

Prevalence of Hypertension and Hypertension Treatment in Patients with Hemophilia

Blood Pressure	UCSD^*	TU^*	LAOH^*
Collection Date Range	2004–2012	2008–2011	2005–2012
Mean collected # (± SD)	2.6 ± 0.7	2.4 ± 0.8	2.9 ± 0.3
Prevalence of HTN			p-value
Overall	52/114 (45.6%)	56/120 (46.7%)	117/224 (52.2%)	.42
18–44 years	17/68 (25.0%)	32/88 (36.4%)	41/127 (32.3%)	.32
45–64 years	23/33 (69.7%)	19/27 (70.4%)	56/75 (74.7%)	.83
65–74 years	11/12 (91.7%)	3/3 (100%)	12/14 (85.7%)	.73
>=75 years	1/1 (100%)	2/2 (100%)	8/8 (100%)	-
Treated HTN	34/114 (29.8%)	24/120 (20.0%)	59/224 (26.3%)	.21

University of California San Diego = UCSD; Tulane University=TU; Los Angeles Orthopedic Hospital (LAOH). HTN=Hypertension; SD=Standard deviation